AIMS/HYPOTHESIS: In the NOD mouse model, attempts to show MHC class II expression by pancreatic beta cells were unsuccessful so far. We readdressed this question by analysing I-A(g7) expression in single pancreatic beta cells. METHODS: Single-cell multiplex RT PCR and single-cell immunofluorescence were used to study MHC class II expression in NOD and NOD/SCID beta cells. RESULTS: Pancreatic beta cells from NOD mice express the I-A(g7) protein as well as the corresponding mRNA. The frequency of MHC class II mRNA-expressing beta cells is drastically increased during the progression to overt diabetes. MHC class II protein is accumulated intracellularly, and invariant chain is co-expressed. Beta cells from 9- to 10-week-old NOD/SCID mice express MHC class II at the same low frequency as beta cells from 3-week-old NOD mice. CONCLUSION/ INTERPRETATION: NOD beta cells express I-A(g7) and could be a direct target of autoreactive CD4+ T cells. This MHC class II expression is triggered by infiltrating lymphocytes.
AIMS/HYPOTHESIS: In the NOD mouse model, attempts to show MHC class II expression by pancreatic beta cells were unsuccessful so far. We readdressed this question by analysing I-A(g7) expression in single pancreatic beta cells. METHODS: Single-cell multiplex RT PCR and single-cell immunofluorescence were used to study MHC class II expression in NOD and NOD/SCID beta cells. RESULTS:Pancreatic beta cells from NOD mice express the I-A(g7) protein as well as the corresponding mRNA. The frequency of MHC class II mRNA-expressing beta cells is drastically increased during the progression to overt diabetes. MHC class II protein is accumulated intracellularly, and invariant chain is co-expressed. Beta cells from 9- to 10-week-old NOD/SCIDmice express MHC class II at the same low frequency as beta cells from 3-week-old NOD mice. CONCLUSION/ INTERPRETATION: NOD beta cells express I-A(g7) and could be a direct target of autoreactive CD4+ T cells. This MHC class II expression is triggered by infiltrating lymphocytes.
Authors: L A O'Reilly; P R Hutchings; P R Crocker; E Simpson; T Lund; D Kioussis; F Takei; J Baird; A Cooke Journal: Eur J Immunol Date: 1991-05 Impact factor: 5.532
Authors: D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann Journal: Nature Date: 1993-11-04 Impact factor: 49.962
Authors: J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman Journal: J Exp Med Date: 1996-04-01 Impact factor: 14.307
Authors: R Rodrigues dos Santos Júnior; A Sartori; V L Deperon Bonato; A A M Coelho Castelo; C A Vilella; R L Zollner; C Lopes Silva Journal: Clin Exp Immunol Date: 2007-06-22 Impact factor: 4.330
Authors: Javier A Collado; Carolina Guitart; M Teresa Ciudad; Iñaki Alvarez; Dolores Jaraquemada Journal: Front Immunol Date: 2013-12-17 Impact factor: 7.561